Literature DB >> 27895782

Expression of MMP9, SERPINE1 and miR-134 as prognostic factors in esophageal cancer.

Anna Agnieszka Klimczak-Bitner1, Radzisław Kordek2, Jan Bitner3, Jacek Musiał4, Janusz Szemraj3.   

Abstract

Esophageal cancer (EC) is a malignant tumor with a typically poor prognosis for patients. It is well known that certain microRNA (miRNA/miR) genes can regulate other genes responsible for carcinogenesis. In the present study, a group of these genes (miR-21, miR-134, miR-205 and miR-495) and genes connected with cancer-related pathways (MET, MMP9, PDGFA and SERPINE1) were chosen for analysis in order to find a potential correlation between their expression and the clinicopathological factors of EC. Esophageal tumors and adjacent non-cancerous tissue specimens were collected from a total of 63 patients and embedded in paraffin. Commercial arrays were used on KYSE-30, KYSE-150 and KYSE-270 EC cell lines in order to find genes of different expression profiles compared with those acquired from the control Het-1A cell line. Quantitative polymerase chain reaction was used on formalin-fixed, paraffin-embedded samples in order to analyze the expression of the genes chosen in the earlier step. The results were analyzed by the Kruskal-Wallis and Mann-Whitney U tests, Spearman's rank correlation coefficient, Kaplan-Meier methods and the long-rank test. Only miR-495 was not expressed in the analyzed samples. The expression of MMP9 and SERPINE1 was significantly coefficient with age range (P=0.011 and P=0.044, respectively) according to the Kruskal-Wallis test. The Spearman's rank-order correlation measurement showed that there was a coefficient correlation between age and miR-134 expression. The same measurement demonstrated a correlation between age range and MMP9 expression. The expression of miR-134 and MMP9 were also found to be correlated. In all cases, a value of P<0.049 was recorded. Overall, the present study demonstrated that MMP9, SERPINE1 and miR-134 were the most prognostic genes in Caucasian patients with EC.

Entities:  

Keywords:  MMP9; SERPINE1; esophageal cancer; genes; miR-134; miRNA databases; microRNA

Year:  2016        PMID: 27895782      PMCID: PMC5104243          DOI: 10.3892/ol.2016.5211

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

Review 1.  Therapeutic options for esophageal cancer.

Authors:  Simon Law; John Wong
Journal:  J Gastroenterol Hepatol       Date:  2004-01       Impact factor: 4.029

Review 2.  Role of microRNAs in plant and animal development.

Authors:  James C Carrington; Victor Ambros
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

3.  The therapeutic potential of microRNAs in cancer.

Authors:  Stine B Thorsen; Susanna Obad; Niels F Jensen; Jan Stenvang; Sakari Kauppinen
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

Review 4.  Tumor metastasis: molecular insights and evolving paradigms.

Authors:  Scott Valastyan; Robert A Weinberg
Journal:  Cell       Date:  2011-10-14       Impact factor: 41.582

Review 5.  Biogenesis of small RNAs in animals.

Authors:  V Narry Kim; Jinju Han; Mikiko C Siomi
Journal:  Nat Rev Mol Cell Biol       Date:  2009-02       Impact factor: 94.444

Review 6.  [Genes responsible for etiopathogenesis in esophageal squamous cell carcinoma].

Authors:  Anna Klimczak; Jan Bitner; Janusz Szemraj
Journal:  Postepy Biochem       Date:  2011

7.  MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.

Authors:  Elisa Giovannetti; Niccola Funel; Godefridus J Peters; Marco Del Chiaro; Leyla A Erozenci; Enrico Vasile; Leticia G Leon; Luca E Pollina; Annemieke Groen; Alfredo Falcone; Romano Danesi; Daniela Campani; Henk M Verheul; Ugo Boggi
Journal:  Cancer Res       Date:  2010-05-11       Impact factor: 12.701

8.  Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.

Authors:  Rie Hamano; Hiroshi Miyata; Makoto Yamasaki; Yukinori Kurokawa; Johji Hara; Jeong Ho Moon; Kiyokazu Nakajima; Shuji Takiguchi; Yoshiyuki Fujiwara; Masaki Mori; Yuichiro Doki
Journal:  Clin Cancer Res       Date:  2011-01-19       Impact factor: 12.531

9.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

10.  Postoperative changes in plasma tissue-type plasminogen activator and type 1 plasminogen activator inhibitor.

Authors:  K Aoki; N Nishino; S Baba; T Urano; A Takada
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

View more
  17 in total

1.  Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.

Authors:  Yinghui Xu; Yanru Wang; Hongliang Liu; Qiong Shi; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Terry Hyslop; Xin Li; Jiali Han; Qingyi Wei
Journal:  Mol Carcinog       Date:  2017-08-28       Impact factor: 4.784

2.  Novel drug candidates for treating esophageal carcinoma: A study on differentially expressed genes, using connectivity mapping and molecular docking.

Authors:  Yu-Ting Chen; Jia-Yi Xie; Qi Sun; Wei-Jia Mo
Journal:  Int J Oncol       Date:  2018-11-02       Impact factor: 5.650

3.  miR-30b-5p acts as a tumor suppressor microRNA in esophageal squamous cell carcinoma.

Authors:  Jianfeng Xu; Haiyan Lv; Bo Zhang; Feng Xu; Hongyu Zhu; Baofu Chen; Chengchu Zhu; Jianfei Shen
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

4.  High expression of PDGFA predicts poor prognosis of esophageal squamous cell carcinoma.

Authors:  Na Han; Yan-Yan Zhang; Zhong-Mian Zhang; Fang Zhang; Teng-Yuan Zeng; Yi-Bing Zhang; Wen-Chao Zhao
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

5.  MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1.

Authors:  Dong-Mei Wu; Shan Wang; Xin Wen; Xin-Rui Han; Yong-Jian Wang; Shao-Hua Fan; Zi-Feng Zhang; Qun Shan; Jun Lu; Yuan-Lin Zheng
Journal:  J Cell Mol Med       Date:  2018-07-19       Impact factor: 5.310

6.  Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer.

Authors:  Ping Liao; Wei Li; Ruizheng Liu; Jamie K Teer; Biaobo Xu; Wei Zhang; Xi Li; Howard L Mcleod; Yijing He
Journal:  Onco Targets Ther       Date:  2018-10-15       Impact factor: 4.147

7.  Prognostic Value of MicroRNAs in Esophageal Carcinoma: A Meta-Analysis.

Authors:  Song Gao; Zhi-Ying Zhao; Zhen-Yong Zhang; Yue Zhang; Rong Wu
Journal:  Clin Transl Gastroenterol       Date:  2018-11-13       Impact factor: 4.488

8.  Identification of MMP9 as a novel key gene in mantle cell lymphoma based on bioinformatic analysis and design of cyclic peptides as MMP9 inhibitors based on molecular docking.

Authors:  Wei Yan; Shawn Xiang Li; Minjie Wei; Hua Gao
Journal:  Oncol Rep       Date:  2018-09-05       Impact factor: 3.906

9.  Robust analysis of novel mRNA-lncRNA cross talk based on ceRNA hypothesis uncovers carcinogenic mechanism and promotes diagnostic accuracy in esophageal cancer.

Authors:  Li-Ping Chen; Hong Wang; Yi Zhang; Qiu-Xiang Chen; Tie-Su Lin; Zong-Qin Liu; Yang-Yang Zhou
Journal:  Cancer Manag Res       Date:  2018-12-27       Impact factor: 3.989

Review 10.  MicroRNAs - novel biomarkers for malignant pleural effusions.

Authors:  Wiktor Wojczakowski; Dominik Kobylarek; Jacek Lindner; Nattakarn Limphaibool; Mariusz Kaczmarek
Journal:  Contemp Oncol (Pozn)       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.